PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3006231

Present and future of acyclovir.

J M Yeo·A P Fiddian
View original source ↗Export metadata ↓

Abstract

Acyclovir is now established as an effective and well tolerated therapeutic agent for the management of at least the more common infections of the herpes virus group. Evaluation of the drug nevertheless continues, primarily to verify its value in those infections caused by cytomegalovirus (CMV) and Epstein-Barr virus (EBV). Furthermore with the development of analogues of acyclovir with better absorption profiles or enhanced anti-viral activity the future for this area of anti-viral therapy looks optimistic.

Explore related subjects

AcyclovirCytomegalovirus InfectionsEncephalitisForecastingHepatitis BHerpes GenitalisHerpes LabialisHerpes SimplexHerpes ZosterHumansImmune ToleranceInfectious MononucleosisKeratitis, DendriticRecurrenceJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Yeo, A P Fiddian. 1985. Present and future of acyclovir.. https://pubmed.ncbi.nlm.nih.gov/3006231/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Synthesis, DNA binding and antiviral activity of new uracil, xanthine, and pteridine derivatives.

Some new 6-amino-1,3-dimethyl-5-(substituted methylidene)aminouracils were synthesized. Most of them were cyclized with triethyl orthoformate as a one-carbon source to afford 1,3-dime-thyl-6-substituted pteridine derivatives. Certain uracils gave xanthine instead of the expected pteridine derivatives upon using another one-carbon source such as triethyl orthoacetate or triethyl orthobenzoate. The nucleic acid binding assay revealed that some new compounds showed high affinity, chelation, and fragmentation of nucleic acids whether DNA or RNA contrary to acyclovir that has affinity to DNA only. The antiviral activity of these novel compounds showed that compounds 2e and 2f reduced the cytopathogencity of Peste des petits ruminant virus (PPRV) on Vero cell culture by 60 and 50%, respectively.

Acyclovir↗